T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: Implications for CNS trafficking

Clinical and Experimental Immunology

Volumn 129, Issue 3, 2002, Pages 510-518

  Kivisakk P ^a   Trebst, C ^a   Liu, Z ^a   Tucky, B H ^a   Sorensen T L ^b   Rudick, R A ^a   Mack, M ^c   Ransohoff, R M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cerebrospinal fluid; Chemokine receptors; Multiple sclerosis; T cells

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CXCR3; LIGAND;

ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID CYTOLOGY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE;

ADULT; ANTIGENS, CD3; ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM; CHEMOTAXIS, LEUKOCYTE; DEMYELINATING AUTOIMMUNE DISEASES, CNS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; T-LYMPHOCYTES;

EID: 0036041995     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01947.x     Document Type: Article

References (56)

1. Axonal damage in acute multiple sclerosis lesions
2. Axonal transection in the lesions of multiple sclerosis
3. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases
4. Lesion development in Marburg's type of acute multiple sclerosis: From inflammation to demyelination
5. Chemokines - Chemotactic cytokines that mediate inflammation
6. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression
7. International union of pharmacology. XXII. Nomenclature for chemokine receptors
8. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
9. Rules of chemokine receptor association with T cell polarization in vivo
10. CCR5 (+) and CXCR3 (+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions
11. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
12. Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions
13. Multiple sclerosis. A study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system
14. Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: Imbalance of Th1/Th2-associated chemokine signaling
15. CCR5 is characteristic of Th1 lymphocytes
16. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions
17. Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes
18. Expression of monocyte chemoattractant protein-1 and interleukin-8 receptors on subsets of T cells: Correlation with transendothelial chemotactic potential
19. Polarization of chemokine receptors to the leading edge during lymphocyte chemotaxis
20. Differential CC chemokine-induced enhancement of T helper cell cytokine production
21. CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection
22. Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue
23. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells
24. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro
25. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody
26. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co- localizing with eosinophils
27. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines
28. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha
29. Lymphocyte phenotype and subset distribution in normal cerebrospinal fluid
30. Adhesion molecule expression on cerebrospinal fluid T lymphocytes: Evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls
31. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling
32. Recommended diagnostic criteria for multiple sclerosis. Guidelines from the International Panel on the diagnosis of multiple sclerosis
33. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro
34. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
35. Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes
36. A standardized protocol for flow cytometric analysis of cells isolated from cerebrospinal fluid
37. Functional and phenotypic properties of 'naive' and 'memory' CD4+ T cells in the human
38. Chemokines. A new classification system and their role in immunity
39. Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies
40. Differential release of beta-chemokines in serum and CSF of patients with relapsing-remitting multiple sclerosis
41. Chemokines CXCL10 and CCL2: Differential involvement in intrathecal inflammation in multiple sclerosis
42. Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon-gamma inducible protein-10 and monocyte chemotactic protein-1
43. Chemokines and chemotaxis of leukocytes in infectious meningitis
44. Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis
45. Surface expression of CC- and CXC-chemokine receptors on leucocyte subsets in inflammatory joint diseases
46. Involvement of the IP-10 chemokine in sarcoid granulomatous reactions
47. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver
48. The CXCR3 activating chemokines IP-10, Mig, and IP-9 are expressed in allergic but not in irritant patch test reactions
49. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation
50. CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis
51. T cell approach to demyelinating diseases
52. T-lymphocyte entry into the central nervous system
53. Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment
54. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing
55. Investigating chemokines and chemokine receptors in patients with multiple sclerosis: Opportunities and challenges
56. Distinct chemokine receptor and cytokine expression profile in secondary progressive MS